相关实验视频

Updated: Jun 29, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

对毛囊淋巴瘤的治疗性疫苗:系统性审查

Andrei Suponin¹, Pavel Zhelnov², Artem Potanin¹

¹RM Gorbacheva Research Institute, Pavlov University, L'va Tolstogo 6-8, 197022 St. Petersburg, Russia.

Pharmaceuticals (Basel, Switzerland)

|March 28, 2024

概括

使用异型钥匙孔的血清素 (Id-KLH) 疫苗进行治疗性疫苗接种,对毛囊性淋巴瘤 (FL) 患者的无进展生存率没有显著差异. 需要进一步的研究来探索FL的免疫疗法开发.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
临床试验临床试验

背景情况:

毛囊性淋巴瘤 (FL) 是一种常见的非霍奇金淋巴瘤.
免疫疗法,包括治疗性疫苗,是FL的不断发展的治疗方式.
估计FL疫苗接种的有效性和安全性对于指导未来免疫疗法开发至关重要.

研究的目的:

汇集在毛囊淋巴瘤 (FL) 中治疗接种疫苗的有效性和安全性数据.
评估患者特异性重组异型密钥孔的血清素 (Id-KLH) 疫苗对无进展生存 (PFS) 的影响.
讨论当前疫苗数据对FL未来免疫疗法策略的影响.

主要方法:

随机对照试验 (RCT) 的系统审查和元分析,涉及FL患者的治疗疫苗.
纳入标准侧重于以PFS作为主要结果的RCT.
在主要数据库和临床试验注册表中进行全面的文献搜索,使用RoB 2.0和ROB-ME.ME进行偏差风险评估.

主要成果:

包括3个RCT,包括813名患者 (先前接受治疗和未接受治疗).
分析表明,使用Id-KLH疫苗的PFS恶化不显著 (危险比:1.09,95%CI:0.91-1.30).
证据的GRADE确定性是中等的,不良事件数据是混合的.

结论:

Id-KLH疫苗在FL患者的PFS中几乎没有显著差异.
目前的证据表明,在研究FL群体中,这种特定疫苗的疗效有限.
这些发现强调需要继续研究毛囊淋巴瘤的新型和更有效的免疫疗法方法.

关键词:

免疫接种免疫接种免疫接种个人参与者数据重建数据重建.非霍奇金性沉默性淋巴瘤

更多相关视频

Intralymphatic Immunotherapy and Vaccination in Mice

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

相关概念视频

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Vaccinations

Vaccinations

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...